Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

DEAR PEOPLE’S PHARMACY: I have suffered from acne and rosacea since I was a teenager. Back then ... After a short time, ...

Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over ...

New research finds that topical ferulic acid significantly improves skin lesions and barrier function in patients with ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

I have suffered from acne and rosacea since I was a teenager. Back then, my dermatologist recommended benzoyl peroxide, but I found it too irritating. Despite trying numerous other treatments, I ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the ...

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...